KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Enterprise Value (2016 - 2025)

Globus Medical (GMED) has disclosed Enterprise Value for 15 consecutive years, with -$557.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 37.39% year-over-year to -$557.2 million, compared with a TTM value of -$557.2 million through Dec 2025, up 37.39%, and an annual FY2025 reading of -$557.2 million, up 37.39% over the prior year.
  • Enterprise Value was -$557.2 million for Q4 2025 at Globus Medical, down from -$18.8 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$18.8 million in Q3 2025 and bottomed at -$890.1 million in Q4 2024.
  • Average Enterprise Value over 5 years is -$474.5 million, with a median of -$468.9 million recorded in 2023.
  • The sharpest move saw Enterprise Value plummeted 71.9% in 2024, then skyrocketed 97.3% in 2025.
  • Year by year, Enterprise Value stood at -$443.4 million in 2021, then fell by 0.59% to -$446.1 million in 2022, then dropped by 16.08% to -$517.8 million in 2023, then tumbled by 71.9% to -$890.1 million in 2024, then skyrocketed by 37.39% to -$557.2 million in 2025.
  • Business Quant data shows Enterprise Value for GMED at -$557.2 million in Q4 2025, -$18.8 million in Q3 2025, and -$229.4 million in Q2 2025.